BIND Therapeutics' Series D Round

BIND Therapeutics raised a round of funding on October 28, 2011.

BIND Therapeutics, formerly BIND Biosciences, is a biopharmaceutical company leveraging its medicinal nanoengineering platform to design, engineer and manufacture targeted therapeutics. Medicinal nano…

Articles about BIND Therapeutics' Series D Round: